Skip to main content

Table 4 Number of patients in each group who reported adverse events.

From: Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: A double-blind randomised placebo controlled 6-month trial

 

Placebo

Paroxetine

nausea

0

4

loss of appetite

1

4

headache

0

1

confusion

0

1

sedation

0

1

flatulence

1

0

hypoglycaemia

0

1

hyperglycaemia

1

0

erectile dysfunction

2

0

sweating

1

1